News
The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for ...
The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...
Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 ...
PharmTech Group spoke with Andy Burns, vice-president of MDI Business Development at Kindeva, ahead of BIO 2025 to find out ...
The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...
The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...
The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.
MilliporeSigma and Simtra Launch Five-Year Agreement for Drug Substance, Drug Manufacturing Services
Simtra BioPharma Solutions, a sterile injectables contract development and manufacturing organization out of Bloomington, Ind. in the United States, has announced a strategic alliance with the Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results